Jump Financial’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-56,780
| Closed | -$2.75M | – | 2067 |
|
2025
Q1 | $2.75M | Buy |
+56,780
| New | +$2.75M | 0.04% | 486 |
|
2024
Q3 | – | Sell |
-5,783
| Closed | -$200K | – | 2027 |
|
2024
Q2 | $200K | Buy |
+5,783
| New | +$200K | ﹤0.01% | 1561 |
|
2023
Q4 | – | Sell |
-35,438
| Closed | -$591K | – | 2143 |
|
2023
Q3 | $591K | Buy |
35,438
+21,070
| +147% | +$351K | 0.02% | 925 |
|
2023
Q2 | $397K | Sell |
14,368
-53,332
| -79% | -$1.47M | 0.01% | 1147 |
|
2023
Q1 | $1.56M | Buy |
+67,700
| New | +$1.56M | 0.06% | 436 |
|
2022
Q4 | – | Sell |
-53,190
| Closed | -$449K | – | 1948 |
|
2022
Q3 | $449K | Buy |
53,190
+1,926
| +4% | +$16.3K | 0.02% | 936 |
|
2022
Q2 | $405K | Buy |
51,264
+16,264
| +46% | +$128K | 0.02% | 937 |
|
2022
Q1 | $829K | Sell |
35,000
-2,100
| -6% | -$49.7K | 0.04% | 599 |
|
2021
Q4 | $1.27M | Buy |
+37,100
| New | +$1.27M | 0.08% | 313 |
|